TechBio

Showing 1–4 of 4

Deep Tech Opportunities Report

DCVC DTOR 2024: TechBio is emerging as the data-centric, AI-native counterweight to biotech

Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis

By Jason Pontin

DCVC leads $35 million financing to help UK TechBio leader Relation Therapeutics to seek new treatments for complex diseases

By Jason Pontin, Zachary Bogue

Davos 2024: A decisive moment for DCVC’s deep tech investment thesis

By Zachary Bogue

Explore Content Topics

View All

Computational Bio & Chem 26

Cybersecurity, Security, & Defense 14

Enterprise Enablement 7

Finance & Insurance 3

Foundational Technology 7

Industrial Transformation 30

Smart Agriculture 14